259 related articles for article (PubMed ID: 26297875)
1. Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom.
Lau WC; Murray M; El-Turki A; Saxena S; Ladhani S; Long P; Sharland M; Wong IC; Hsia Y
Vaccine; 2015 Sep; 33(39):5072-9. PubMed ID: 26297875
[TBL] [Abstract][Full Text] [Related]
2. Impact of pneumococcal conjugate vaccines on healthcare utilization and direct costs for otitis media in children ≤2 years of age in two Swedish regions.
Edmondson-Jones M; Dibbern T; Hultberg M; Anell B; Medin E; Feng Y; Talarico C
Hum Vaccin Immunother; 2022 Dec; 18(1):1942712. PubMed ID: 34319865
[TBL] [Abstract][Full Text] [Related]
3. Changes in Otitis Media Episodes and Pressure Equalization Tube Insertions Among Young Children Following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine: A Birth Cohort-based Study.
Wiese AD; Huang X; Yu C; Mitchel EF; Kyaw MH; Griffin MR; Grijalva CG
Clin Infect Dis; 2019 Nov; 69(12):2162-2169. PubMed ID: 30770533
[TBL] [Abstract][Full Text] [Related]
4. Substantial reduction of antibiotic-non-susceptible pneumococcal otitis media following PCV7/PCV13 sequential introduction.
Ben-Shimol S; Givon-Lavi N; Greenberg D; van der Beek BA; Leibovitz E; Dagan R
J Antimicrob Chemother; 2020 Oct; 75(10):3038-3045. PubMed ID: 32946586
[TBL] [Abstract][Full Text] [Related]
5. Pan-serotype Reduction in Progression of Streptococcus pneumoniae to Otitis Media After Rollout of Pneumococcal Conjugate Vaccines.
Lewnard JA; Givon-Lavi N; Weinberger DM; Lipsitch M; Dagan R
Clin Infect Dis; 2017 Nov; 65(11):1853-1861. PubMed ID: 29020218
[TBL] [Abstract][Full Text] [Related]
6. The effect of pneumococcal conjugate vaccines on otitis media from 2005 to 2013 in children aged ≤5 years: a retrospective cohort study in two Swedish regions.
Edmondson-Jones M; Dibbern T; Hultberg M; Anell B; Medin E; Feng Y; Talarico C
Hum Vaccin Immunother; 2021 Feb; 17(2):517-526. PubMed ID: 32574101
[TBL] [Abstract][Full Text] [Related]
7. Impact of Widespread Introduction of Pneumococcal Conjugate Vaccines on Pneumococcal and Nonpneumococcal Otitis Media.
Ben-Shimol S; Givon-Lavi N; Leibovitz E; Raiz S; Greenberg D; Dagan R
Clin Infect Dis; 2016 Sep; 63(5):611-8. PubMed ID: 27225239
[TBL] [Abstract][Full Text] [Related]
8. Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling study.
Choi YH; Andrews N; Miller E
PLoS Med; 2019 Jul; 16(7):e1002845. PubMed ID: 31269018
[TBL] [Abstract][Full Text] [Related]
9. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.
Waight PA; Andrews NJ; Ladhani SN; Sheppard CL; Slack MP; Miller E
Lancet Infect Dis; 2015 May; 15(5):535-43. PubMed ID: 25801458
[TBL] [Abstract][Full Text] [Related]
10. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
[TBL] [Abstract][Full Text] [Related]
11. Pneumococcal carriage and serotype variation before and after introduction of pneumococcal conjugate vaccines in patients with acute otitis media in Switzerland.
Allemann A; Frey PM; Brugger SD; Hilty M
Vaccine; 2017 Apr; 35(15):1946-1953. PubMed ID: 28279564
[TBL] [Abstract][Full Text] [Related]
12. Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study.
Ladhani SN; Collins S; Djennad A; Sheppard CL; Borrow R; Fry NK; Andrews NJ; Miller E; Ramsay ME
Lancet Infect Dis; 2018 Apr; 18(4):441-451. PubMed ID: 29395999
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel.
Ben-Shimol S; Givon-Lavi N; Greenberg D; Dagan R
Hum Vaccin Immunother; 2016; 12(2):268-76. PubMed ID: 26430921
[TBL] [Abstract][Full Text] [Related]
14. National impact of 13-valent pneumococcal conjugate vaccine on ambulatory care visits for otitis media in children under 5 years in the United States.
Zhou X; de Luise C; Gaffney M; Burt CW; Scott DA; Gatto N; Center KJ
Int J Pediatr Otorhinolaryngol; 2019 Apr; 119():96-102. PubMed ID: 30690309
[TBL] [Abstract][Full Text] [Related]
15. Incidence of acute otitis media from 2003 to 2019 in children ≤ 17 years in England.
Mohanty S; Podmore B; Cuñado Moral A; Weiss T; Matthews I; Sarpong E; Méndez I; Qizilbash N
BMC Public Health; 2023 Jan; 23(1):201. PubMed ID: 36717794
[TBL] [Abstract][Full Text] [Related]
16. Reduction of invasive pneumococcal disease 3 years after the introduction of the 13-valent conjugate vaccine in the Oxfordshire region of England.
Moore CE; Paul J; Foster D; Mahar SA; Griffiths D; Knox K; Peto TE; Walker AS; Crook DW;
J Infect Dis; 2014 Oct; 210(7):1001-11. PubMed ID: 24719477
[TBL] [Abstract][Full Text] [Related]
17. Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV.
Ben-Shimol S; Givon-Lavi N; Leibovitz E; Raiz S; Greenberg D; Dagan R
Clin Infect Dis; 2014 Dec; 59(12):1724-32. PubMed ID: 25159581
[TBL] [Abstract][Full Text] [Related]
18. Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.
Lepoutre A; Varon E; Georges S; Dorléans F; Janoir C; Gutmann L; Lévy-Bruhl D; ;
Vaccine; 2015 Jan; 33(2):359-66. PubMed ID: 25448105
[TBL] [Abstract][Full Text] [Related]
19. Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era.
Wiese AD; Griffin MR; Zhu Y; Mitchel EF; Grijalva CG
Vaccine; 2016 Dec; 34(50):6243-6249. PubMed ID: 27832918
[TBL] [Abstract][Full Text] [Related]
20. Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children.
Esposito S; Principi N
J Immunol Res; 2015; 2015():591580. PubMed ID: 26351648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
